Find clinical trials for Triple Negative Breast Cancer in San Antonio, TX

This is a 3-arm study stratified by plasma ctDNA. Patients with residual TNBC disease after pre-operative therapy will be assigned to 1 of 3 Arms bas...

This trial studies ladiratuzumab vedotin (LV) with pembrolizumab in patients with triple-negative breast cancer. -...

or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...

This study will assess the efficacy and safety of Niraparib in participants with either tumor mutation in the BRCA gene (tBRCAmut) HER2- breast...

This study is one single group of participants with non-small cell lung cancer (NSCLC) who have not been cured by other treatments. It is th...

This is a Phase III, randomised, open-label, 2 arm, multicentre, international study assessing the efficacy and safety of Dato-DXd compared with ICC...

previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors...

AGX101 is an antibody-drug conjugate (ADC) therapy for tumor-forming cancers. The purpose of this study is to learn about AGX101 ef...

after induction with first-line chemotherapy plus pembrolizumab in triple negative breast cancer (TNBC). The prim...

with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors...